Jean-Paul Ortonne

Overview

Best Publications

• Infliximab induction and maintenance therapy for moderate-to-severe psoriasis : a phase III, multicentre, double-blind trial

  Kristian Reich;Frank O Nestle;Kim Papp;Jean-Paul Ortonne

  1328
  Citations

• Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

  Kim A Papp;Craig Leonardi;Alan Menter;Jean-Paul Ortonne

  1167
  Citations

• Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).

  Jean-Hilaire Saurat;G. Stingl;L. Dubertret;K. Papp

  865
  Citations

• Microphthalmia Gene Product as a Signal Transducer in cAMP-Induced Differentiation of Melanocytes

  Corine Bertolotto;Patricia Abbe;Timothy J. Hemesath;Karine Bille

  611
  Citations

• An International, Randomized, Double-blind, Placebo-Controlled Phase 3 Trial of Intramuscular Alefacept in Patients With Chronic Plaque Psoriasis

  Mark Lebwohl;Enno Christophers;Richard Langley;Jean P. Ortonne

  500
  Citations

• Integrin β4 mutations associated with junctional epidermolysis bullosa with pyloric atresia

  Frédérique Vidal;Daniel Aberdam;Corinne Miquel;Angela M. Christiano

  443
  Citations

• Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug

  Alexander Kapp;Kim Papp;Ann Bingham;Regina Fölster-Holst

  412
  Citations

• Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LAMININ-5)

  Aberdam D;Galliano Mf;Vailly J;Pulkkinen L

  401
  Citations

• Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study.

  Phoebe Rich;B. Sigurgeirsson;D. Thaci;J. P. Ortonne

  369
  Citations

• A classification of psoriasis vulgaris according to phenotype

  C. E M Griffiths;E. Christophers;J. N W N Barker;R. J G Chalmers

  354
  Citations

• Inhibition of the Phosphatidylinositol 3-Kinase/p70S6-Kinase Pathway Induces B16 Melanoma Cell Differentiation

  Roser Buscà;Corine Bertolotto;Jean-Paul Ortonne;Robert Ballotti

  331
  Citations

• Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis

  Axel Patrice Villani;Marie Rouzaud;Morgane Sevrain;Thomas Barnetche

  328
  Citations

• Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?

  K.U. Schallreuter;P. Bahadoran;M. Picardo;A. Slominski

  307
  Citations

• Topical Tacrolimus and the 308-nm Excimer Laser A Synergistic Combination for the Treatment of Vitiligo

  Thierry Passeron;Nima Ostovari;Wassim Zakaria;Eric Fontas

  307
  Citations

• Biological therapies in the systemic management of psoriasis: International Consensus Conference.

  W. Sterry;J. Barker;W.H. Boehncke;J.D. Bos

  293
  Citations

• Roaccutane treatment guidelines: results of an international survey.

  W.J. Cunliffe;P.C.M. van de Kerkhof;R. Caputo;S. Cavicchini

  292
  Citations

• Monoclonal antibody GB3, a new probe for the study of human basement membranes and hemidesmosomes.

  Patrick Verrando;Bae-Li Hsi;Chang-Jing Yeh;Anne Pisani

  267
  Citations

• A 52-Week Trial Comparing Briakinumab with Methotrexate in Patients with Psoriasis

  Kristian Reich;Richard G. Langley;Kim A. Papp;Jean-Paul Ortonne

  255
  Citations

• Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris.

  William J. Cunliffe;John Berth-Jones;Alain Claudy;Geoffrey Fairiss

  239
  Citations

• Involvement of microphthalmia in the inhibition of melanocyte lineage differentiation and of melanogenesis by agouti signal protein.

  E Aberdam;C Bertolotto;E V Sviderskaya;V de Thillot

  234
  Citations